|
USRE33080E
(en)
*
|
1981-08-31 |
1989-10-03 |
Exxon Research And Engineering Company |
Adamantane catalyzed paraffin isomerization
|
|
US5506231A
(en)
*
|
1989-03-31 |
1996-04-09 |
The Children's Medical Center Corporation |
Treatment of aids dementia, myelopathy and blindness
|
|
US5455279A
(en)
*
|
1991-04-19 |
1995-10-03 |
The Children's Medical Center Corporation |
Regimen method of mediating neuronal damage using nitroglycerine
|
|
US5614560A
(en)
*
|
1991-04-04 |
1997-03-25 |
Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
DE19707655A1
(de)
*
|
1997-02-26 |
1998-08-27 |
Hoechst Ag |
Kombinationspräparat zur Anwendung bei Demenz
|
|
US20040122090A1
(en)
*
|
2001-12-07 |
2004-06-24 |
Lipton Stuart A. |
Methods for treating neuropsychiatric disorders with nmda receptor antagonists
|
|
CN100339070C
(zh)
|
2002-10-24 |
2007-09-26 |
莫茨药物股份两合公司 |
包含1-氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物
|
|
UA80055C2
(en)
*
|
2003-05-27 |
2007-08-10 |
Forest Laboratories |
Combination of nmda-receptor antagonist and selective inhibitor of serotonin reuptake for a depression and other pscihiatric disorders treatment
|
|
BRPI0411451A
(pt)
*
|
2003-06-16 |
2006-07-18 |
Allergan Inc |
formas de dosagens orais de memantina
|
|
AU2004316119B2
(en)
*
|
2003-10-22 |
2008-04-24 |
Merz Pharma Gmbh & Co. Kgaa |
The use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic AB peptides in amyloidopathies
|
|
AR046314A1
(es)
|
2003-11-05 |
2005-11-30 |
Merz Pharma Gmbh & Co Kgaa |
Composiciones que comprenden ciclohexilaminas y aminoadamantanos
|
|
SI1703902T1
(sl)
*
|
2004-01-05 |
2011-02-28 |
Merz Pharma Gmbh & Co Kgaa |
Memantin za zdravljenje blage do zmerne Alzheimerjeve bolezni
|
|
US7456224B2
(en)
*
|
2004-04-05 |
2008-11-25 |
Forest Laboratories Holdings, Ltd. |
Method for treating autism
|
|
WO2006009769A1
(fr)
*
|
2004-06-17 |
2006-01-26 |
Forest Laboratories, Inc. |
Formulation de liberation modifiee de memantine
|
|
BRPI0512263A
(pt)
|
2004-06-17 |
2008-02-26 |
Merz Pharma Gmbh & Co Kgaa |
formulações de liberação imediata de formas de dosagem oral de memantina
|
|
US20060002999A1
(en)
|
2004-06-17 |
2006-01-05 |
Forest Laboratories, Inc. |
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
|
|
TW200616608A
(en)
*
|
2004-07-09 |
2006-06-01 |
Forest Laboratories |
Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
|
|
US20060079582A1
(en)
*
|
2004-09-23 |
2006-04-13 |
Jeffrey Jonas |
Memantine for the treatment of childhood behavioral disorders
|
|
US8058291B2
(en)
|
2005-04-06 |
2011-11-15 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of CNS-related conditions
|
|
US7619007B2
(en)
*
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
US20060205822A1
(en)
*
|
2004-12-22 |
2006-09-14 |
Forest Laboratories, Inc. |
1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
|
|
EA013474B1
(ru)
*
|
2005-06-16 |
2010-04-30 |
Форест Лэборэтериз, Инк. |
Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
|
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|
|
EP2040676A2
(fr)
*
|
2006-07-06 |
2009-04-01 |
Forest Laboratories, Inc. |
Formulations à dissolution orale de mémantine
|
|
TW200823215A
(en)
|
2006-08-04 |
2008-06-01 |
Merz Pharma Gmbh & Amp Co Kgaa |
Pyrazolopyrimidines, a process for their preparation and the use as a medicine
|
|
WO2008063847A2
(fr)
*
|
2006-11-03 |
2008-05-29 |
Forest Laboratories Holdings Limited |
Méthode de traitement de l'autisme
|
|
EP2090576A1
(fr)
|
2008-02-01 |
2009-08-19 |
Merz Pharma GmbH & Co.KGaA |
6-halo-pyrazolo[1,5-a]pyridines, leur procédé de préparation et leur utilisation en tant que modulateurs des récepteurs metabotropiques du glutamate (mGluR)
|
|
EP2085398A1
(fr)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, leur procédé de préparation et leur utilisation en tant que médicament
|
|
US20090247644A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Forest Laboratories Holdings Limited |
Memantine formulations
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
EP2111858A1
(fr)
|
2008-04-25 |
2009-10-28 |
EPFL Ecole Polytechnique Fédérale de Lausanne |
Nouveau traitement pour la maladie d'Alzheimer
|
|
US20090275597A1
(en)
*
|
2008-05-02 |
2009-11-05 |
Forest Laboratories Holdings Limited |
Methods of treating cns disorders
|
|
EP2138173A1
(fr)
|
2008-06-26 |
2009-12-30 |
Merz Pharma GmbH & Co.KGaA |
Compositions pharmaceutiques comportant des dérivés d'aminoadamantane
|
|
TW201116532A
(en)
|
2009-08-05 |
2011-05-16 |
Merz Pharma Gmbh & Co Kgaa |
Metabotropic glutamate receptor modulators
|
|
JP5885668B2
(ja)
|
2009-12-02 |
2016-03-15 |
アダマス ファーマシューティカルズ, インコーポレイテッド |
アマンタジン組成物および使用方法
|
|
US20110251239A1
(en)
|
2010-04-07 |
2011-10-13 |
Eisai Inc. |
Combination therapy for the treatment of dementia
|
|
WO2012052451A1
(fr)
|
2010-10-18 |
2012-04-26 |
Merz Pharma Gmbh & Co. Kgaa |
Modulateurs des récepteurs métabotropes au glutamate
|
|
JP5848768B2
(ja)
|
2010-10-29 |
2016-01-27 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドRamot At Tel Aviv University Ltd. |
インドール誘導体及びその製造方法
|
|
AU2011328993B2
(en)
|
2010-11-15 |
2017-03-02 |
Agenebio, Inc. |
Pyridazine derivatives, compositions and methods for treating cognitive impairment
|
|
AR084515A1
(es)
|
2010-12-22 |
2013-05-22 |
Merz Pharma Gmbh & Co Kgaa |
Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras
|
|
WO2012085166A1
(fr)
|
2010-12-22 |
2012-06-28 |
Merz Pharma Gmbh & Co. Kgaa |
Modulateurs des récepteurs glutamatergiques métabotropes
|
|
WO2012152854A1
(fr)
|
2011-05-12 |
2012-11-15 |
Merz Pharma Gmbh & Co. Kgaa |
Modulateurs de récepteur de glutamate métabotropique
|
|
WO2012172093A1
(fr)
|
2011-06-17 |
2012-12-20 |
Merz Pharma Gmbh & Co. Kgaa |
Dérivé de dihydroindolizine à titre de modulateurs des récepteurs métabotropes de glutamate
|
|
EP2650284A1
(fr)
|
2012-04-10 |
2013-10-16 |
Merz Pharma GmbH & Co. KGaA |
Dérivés hétérocycliques comme modulateurs de récepteurs du glutamate métabotropique
|
|
RU2488388C1
(ru)
|
2012-05-24 |
2013-07-27 |
Ооо "Валента Интеллект" |
Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
|
|
DK2892540T3
(en)
*
|
2012-09-06 |
2018-11-19 |
Mcpharma Biotech Inc |
TREATMENT OF DIARRES AND DRAWN DIARRES WITH RESISTANT POTATO STARCH
|
|
WO2014204933A1
(fr)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Compositions d'amantadine et procédés d'utilisation
|
|
EP4032889B1
(fr)
|
2013-12-20 |
2026-05-06 |
Agenebio, Inc. |
Dérivés de benzodiazépine, compositions et méthodes de traitement de déficience cognitive
|
|
CA2938671A1
(fr)
|
2014-02-04 |
2015-08-13 |
Forest Laboratories Holdings Limited |
Compositions de donepezil et procede de traitement de la maladie d'alzheimer
|
|
EP3310785B1
(fr)
|
2015-06-19 |
2024-11-20 |
Agenebio, Inc. |
Dérivés de benzodiazépine, compositions et méthodes de traitement de la déficience cognitive
|
|
US10835499B2
(en)
|
2015-12-30 |
2020-11-17 |
Corium, Inc. |
Systems and methods for long term transdermal administration
|
|
CN109922796B
(zh)
|
2016-06-23 |
2023-04-07 |
考里安有限责任公司 |
具有亲水和疏水域的粘合剂基质和治疗剂
|
|
KR102424270B1
(ko)
|
2016-07-27 |
2022-07-25 |
코리움, 인크. |
경구 전달과 생물학적으로 동등한 약물동역학을 가진 경피 전달 시스템
|
|
EP3490544A1
(fr)
|
2016-07-27 |
2019-06-05 |
Corium International, Inc. |
Systèmes d'administration transdermique de mémantine
|
|
JP7071330B2
(ja)
|
2016-07-27 |
2022-05-18 |
コリウム, インコーポレイテッド |
炭酸水素ナトリウムのin situ変換で促進されたアミン薬物の経皮送達
|
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
US10369187B2
(en)
|
2017-02-09 |
2019-08-06 |
Vanderbilt University |
Peptide regulators of JNK family kinases
|
|
WO2019126531A1
(fr)
|
2017-12-20 |
2019-06-27 |
Corium, Inc. |
Composition adhésive transdermique comprenant un agent thérapeutique liquide volatil à bas point de fusion
|
|
AU2019288382B2
(en)
|
2018-06-19 |
2024-07-25 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
EP4475953A1
(fr)
|
2022-02-08 |
2024-12-18 |
Fikret SAHIN |
Antagonistes nmdar prévenant le vieillissement et les troubles et maladies associées au vieillissement en augmentant l'activité du protéasome 20s
|
|
EP4572852A1
(fr)
|
2022-08-19 |
2025-06-25 |
Agenebio, Inc. |
Dérivés de benzoazépine, compositions et méthodes de traitement de déficience cognitive
|